{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:55:35Z","timestamp":1760244935835},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.transproceed.2006.10.216","type":"journal-article","created":{"date-parts":[[2007,2,3]],"date-time":"2007-02-03T07:47:43Z","timestamp":1170488863000},"page":"103-108","source":"Crossref","is-referenced-by-count":21,"title":["Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Maintenance Renal Transplant Patients: Pooled Results From Three International, Multicenter Studies"],"prefix":"10.1016","volume":"39","author":[{"given":"F.","family":"Pietruck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Abbud-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vathsala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.U.","family":"Massari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Po-Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Nashan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.10.216_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in cadaveric renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.10.216_bib2","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for the prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2006.10.216_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.10.216_bib4","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1681\/ASN.V11122366","article-title":"Effect of mycophenolate mofetil on long-term outcomes in African American renal transplant recipients","volume":"11","author":"Meier-Kriesche","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.10.216_bib5","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2006.10.216_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.transproceed.2006.10.216_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation","volume":"17","author":"Pelletier","year":"2002","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2006.10.216_bib8","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2006.10.216_bib9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-2277.2004.tb00394.x","article-title":"Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil","volume":"17","author":"Hardinger","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2006.10.216_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","article-title":"Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients","volume":"19","author":"Tierce","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2006.10.216_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.10.216_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2006.10.216_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.transproceed.2004.12.048","article-title":"Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study","volume":"37","author":"Budde","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2006.10.216_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506014795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134506014795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T09:10:29Z","timestamp":1628413829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134506014795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0041134506014795"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.10.216","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}